{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:22:08Z","timestamp":1791256928735,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.annder.2008.10.044","type":"journal-article","created":{"date-parts":[[2009,5,27]],"date-time":"2009-05-27T04:32:13Z","timestamp":1243398733000},"page":"740-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Physiopathologie de la pemphigo\u00efde bulleuse"],"prefix":"10.1016","volume":"136","author":[{"given":"V.","family":"Doffoel-Hantz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cogn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Drouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sparsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Bonnetblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"B\u00e9dane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2008.10.044_bib1","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","article-title":"Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence","volume":"41","author":"Jung","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archderm.1995.01690200097021","article-title":"Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany","volume":"131","author":"Zillikens","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib4","doi-asserted-by":"crossref","first-page":"a209","DOI":"10.1136\/bmj.a209","article-title":"Incidence of bullous pemphigoid and pemphigus vulgaris","volume":"337","author":"Joly","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.annder.2008.10.044_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/archderm.1996.03890270044006","article-title":"Drugs associated with bullous pemphigoid. A case-control study","volume":"132","author":"Bastuji-Garin","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib6","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0190-9622(81)70116-6","article-title":"Bullous pemphigoid and Hashimoto's thyroiditis","volume":"5","author":"Callen","year":"1981","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib7","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1007\/s10620-004-9567-2","article-title":"The association of bullous pemphigoid and ulcerative colitis","volume":"49","author":"Selby","year":"2004","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.annder.2008.10.044_bib8","first-page":"349","article-title":"Pemphigo\u00efde bulleuse, cirrhose biliaire primitive et vitiligo\u00a0: un syndrome auto-immun multiple\u00a0?","volume":"153","author":"Marcet","year":"2002","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.annder.2008.10.044_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5070\/D35Q17B9W1","article-title":"Coexistence of bullous pemphigoid, vitiligo, and thyroid disease: a multiple autoimmune syndrome?","volume":"11","author":"Tirado-Sanchez","year":"2005","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.annder.2008.10.044_bib10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/00015550510034146","article-title":"Bullous pemphigoid and Graves\u2019 disease: an association between skin and thyroid autoimmunity","volume":"85","author":"Fiorucci","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.annder.2008.10.044_bib11","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1365-2133.1997.tb14972.x","article-title":"The multiple autoimmune syndromes (MAS)","volume":"136","author":"Humbert","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0190-9622(93)70164-O","article-title":"Bullous pemphigoid and autoimmunity","volume":"29","author":"Taylor","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib13","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2133.1990.tb01447.x","article-title":"The association of bullous pemphigoid and malignant disease: a case control study","volume":"123","author":"Venning","year":"1990","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2133.1985.tb02079.x","article-title":"Evidence of an association between bullous pemphigoid and psoriasis","volume":"113","author":"Grattan","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2133.1985.tb02041.x","article-title":"Lichen planus pemphigoid: an immuno-electron microscopic study","volume":"113","author":"Prost","year":"1985","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.1523-1747.1998.00107.x","article-title":"Epitope spreading: lessons from autoimmune skin diseases","volume":"110","author":"Chan","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.radonc.2006.11.014","article-title":"Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side-effect","volume":"82","author":"Mul","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.annder.2008.10.044_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2230.1995.tb01375.x","article-title":"Bullous pemphigoid and multiple sclerosis: a report of three cases and review of the literature","volume":"20","author":"Kirtschig","year":"1995","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archderm.136.4.521","article-title":"Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease?","volume":"136","author":"Chosidow","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib20","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/j.1346-8138.1998.tb02436.x","article-title":"Bullous pemphigoid associated with Shy-Drager syndrome","volume":"25","author":"Okazaki","year":"1998","journal-title":"J Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib21","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1365-2133.1993.tb03188.x","article-title":"Unilateral bullous pemphigoid in a hemiplegic patient","volume":"129","author":"Bunker","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0151-9638(06)70935-8","article-title":"Corr\u00e9lation entre la pr\u00e9sence d\u2019anticorps anti-antig\u00e8ne de type 2 de la pemphigo\u00efde bulleuse et d\u00e9mence chez les sujets \u00e2g\u00e9s sans manifestation clinique de pemphigo\u00efde bulleuse","volume":"133","author":"Foureur","year":"2006","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2008.10.044_bib23","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1083\/jcb.200012098","article-title":"The BPAG1 locus: Alternative splicing produces multiple isoforms with distinct cytoskeletal linker domains, including predominant isoforms in neurons and muscles","volume":"154","author":"Leung","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1016\/j.annder.2008.10.044_bib24","first-page":"S7","article-title":"Etude \u00e9pid\u00e9miologique prospective des facteurs de risque de la pemphigo\u00efde","volume":"134","author":"Bastuji-Garin","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2008.10.044_bib25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1046\/j.1523-1747.2002.01720.x","article-title":"Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin","volume":"118","author":"Sitaru","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archderm.136.2.174","article-title":"Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid","volume":"136","author":"Schmidt","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib27","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archderm.1977.01640080071010","article-title":"Immunopathologic study of herpes gestationis in mother and infant","volume":"113","author":"Katz","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib28","first-page":"817","article-title":"Physiopathologie des dermatoses bulleuses auto-immunes de la jonction dermo-\u00e9pidermique","volume":"125","author":"Salmon-Ehr","year":"1998","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2008.10.044_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/1523-1747.ep12259224","article-title":"Identification and partial characterization of pemphigoid antigen extracted from normal human skin","volume":"82","author":"Stanley","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1046\/j.1523-1747.1998.00452.x","article-title":"Interaction of BP180 (type XVII collagen) and alpha-6 integrin is necessary for stabilization of hemidesmosome structure","volume":"111","author":"Hopkinson","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.tcb.2006.05.004","article-title":"Current insights into the formation and breakdown of hemidesmosomes","volume":"16","author":"Litjens","year":"2006","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.annder.2008.10.044_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00403-007-0734-0","article-title":"The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases","volume":"299","author":"Sitaru","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.annder.2008.10.044_bib33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/1523-1747.ep12338088","article-title":"A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid","volume":"109","author":"Zillikens","year":"1997","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib34","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1365-2133.1998.02396.x","article-title":"Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180\u00a0kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins","volume":"139","author":"Nakatani","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib35","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.0022-202X.2003.22126.x","article-title":"Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients","volume":"122","author":"Di Zenzo","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1046\/j.1523-1747.2003.12071.x","article-title":"Memory, B cells specific for the NC16A domain of the 180\u00a0kDa bullous pemphigoid autoantigen can be detected in peripheral blood of bullous pemphigoid patients and induced in vitro to synthesize autoantibodies","volume":"120","author":"Leyendeckers","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib37","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1046\/j.1523-1747.2000.00893.x","article-title":"IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230","volume":"114","author":"Skaria","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib38","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1023\/A:1020531005776","article-title":"IgE antibodies in sera from patients with bullous pemphigoid are autoantibodies preferentially directed against the 230-kDa epidermal antigen (BP230)","volume":"18","author":"Ghohestani","year":"1998","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.annder.2008.10.044_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.0022-202X.2005.23853.x","article-title":"Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid","volume":"125","author":"Fairley","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib40","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1038\/sj.jid.5700958","article-title":"A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu\/nu mice","volume":"127","author":"Fairley","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archdermatol.2007.9","article-title":"Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid","volume":"144","author":"Iwata","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.annder.2008.10.044_bib43","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0190-9622(98)70129-X","article-title":"A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180\u00a0kd bullous pemphigoid antigen and laminin 5","volume":"38","author":"Kawahara","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1365-2133.2001.03963.x","article-title":"Plectin, an unusual target antigen in bullous pemphigoid","volume":"144","author":"Laffitte","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib45","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archderm.1977.01640080045002","article-title":"Bullous pemphigoid, clinical and immunologic follow-up after successful therapy","volume":"113","author":"Ahmed","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib46","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/1523-1747.ep12507222","article-title":"An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement","volume":"78","author":"Gammon","year":"1982","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1087-0024.2004.00841.x","article-title":"Bullous pemphigoid: using animal models to study the immunopathology","volume":"9","author":"Liu","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.annder.2008.10.044_bib48","first-page":"s21","article-title":"Induction of bullous pemphigoid and pemphigoid gestationis in humanized BP180NC16A mice by passive transfer of autoantibodies from patients","volume":"126","author":"Liu","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1523-1747.ep12358276","article-title":"Rabbits immunized with a peptide encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: a potential animal model for bullous pemphigoid","volume":"101","author":"Hall","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2004.09.007","article-title":"Experimental bullous pemphigoid generated in mice with an antigenic epitope of the human hemidesmosomal protein BP230","volume":"24","author":"Kiss","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1016\/j.annder.2008.10.044_bib51","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.0022-202X.2004.22603.x","article-title":"BP230- and BP180-specific auto-antibodies in bullous pemphigoid","volume":"122","author":"Thoma-Uszynski","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/1523-1747.ep12259679","article-title":"Deposition of the membrane attack complex of complement in bullous pemphigoid","volume":"82","author":"Dahl","year":"1984","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib53","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1172\/JCI17891","article-title":"Role of different pathways of the complement cascade in experimental bullous pemphigoid","volume":"116","author":"Nelson","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annder.2008.10.044_bib54","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1172\/JCI117826","article-title":"The role of complement in experimental bullous pemphigoid","volume":"95","author":"Liu","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annder.2008.10.044_bib55","first-page":"11","article-title":"Increased serum IL-6, TNF-alpha and IL-10 levels in patients with bullous pemphigoid: relationships with disease activity","volume":"12","author":"D\u2019Auria","year":"1999","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2008.10.044_bib56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yadr.2007.07.013","article-title":"Bullous pemphigoid: physiopathology, clinical features and management","volume":"23","author":"Di Zenzo","year":"2007","journal-title":"Adv Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib57","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/1523-1747.ep12606974","article-title":"Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme","volume":"104","author":"Brown","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib58","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI117196","article-title":"92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen","volume":"93","author":"Stahle-Backdahl","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annder.2008.10.044_bib59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1172\/JCI3693","article-title":"A critical role for neutrophil elastase in experimental bullous pemphigoid","volume":"105","author":"Liu","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annder.2008.10.044_bib60","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI23977","article-title":"Synergy between a plasminogen cascade and MMP-9 in autoimmune disease","volume":"115","author":"Liu","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annder.2008.10.044_bib61","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/1523-1747.ep12525315","article-title":"Mononuclear cell infiltrates in bullous disease","volume":"88","author":"Nestor","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib62","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1046\/j.1523-1747.2000.00153.x","article-title":"Epitopes targeted by bullous pemphigoid T\u00a0lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid\u00a0180\u00a0ectodomain","volume":"115","author":"Lin","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib63","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.4049\/jimmunol.162.8.4991","article-title":"Identification and characterization of epitopes recognized by T\u00a0lymphocytes and autoantibodies from patients with herpes gestationis","volume":"162","author":"Lin","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.annder.2008.10.044_bib64","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1172\/JCI3335","article-title":"Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen\u00a02 in patients and healthy controls","volume":"102","author":"Budinger","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.annder.2008.10.044_bib65","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.176.3.2015","article-title":"Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230","volume":"176","author":"Thoma-Uszynski","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.annder.2008.10.044_bib66","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1073\/pnas.93.16.8569","article-title":"A common major histocompatibility complex class II allele HLA-DQB1* 0301 is present in clinical variants of pemphigoid","volume":"93","author":"Delgado","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.annder.2008.10.044_bib67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00372706","article-title":"The interleukin-2 receptor in lesions and serum of bullous pemphigoid","volume":"284","author":"Zillikens","year":"1992","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.annder.2008.10.044_bib68","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000236199","article-title":"Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology","volume":"98","author":"Romagnani","year":"1992","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.annder.2008.10.044_bib69","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1468-3083.2006.02122.x","article-title":"Pancytopenia induced by low-dose methotrexate in a haemodialysis patient treated for bullous pemphigoid","volume":"21","author":"Seneschal","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2008.10.044_bib70","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0190-9622(94)70227-6","article-title":"Low-dose methotrexate treatment in elderly patients with bullous pemphigoid","volume":"31","author":"Paul","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib71","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0190-9622(99)70156-8","article-title":"Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid","volume":"40","author":"Heilborn","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib72","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/archderm.138.9.1255","article-title":"Treatment of bullous pemphigoid by low-dose methotrexate associated with short-term potent topical steroids: an open prospective study of 18\u00a0cases","volume":"138","author":"Dereure","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib73","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1001\/archderm.139.11.1506-b","article-title":"Methotrexate for bullous pemphigoid: preliminary study","volume":"139","author":"Bara","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib74","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1001\/archderm.136.10.1204","article-title":"Bullous pemphigoid treated with leflunomide: a novel immunomodulatory agent","volume":"136","author":"Nousari","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib75","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2230.2006.02151.x","article-title":"Rituximab in refractory autoimmune bullous diseases","volume":"31","author":"Schmidt","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib76","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-2133.2006.07646.x","article-title":"Rituximab in autoimmune bullous diseases: mixed responses and adverse effects","volume":"156","author":"Schmidt","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2008.10.044_bib77","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/sj.bmt.1703654","article-title":"Combination treatment of bullous pemphigoid with anti-CD20 and anti-CD25 antibodies in a patient with chronic graft-versus-host disease","volume":"30","author":"Szabolcs","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.annder.2008.10.044_bib78","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000106585","article-title":"Epidermolysis bullosa acquisita following bullous pemphigoid, successfully treated with the anti-CD20 monoclonal antibody rituximab","volume":"215","author":"Wallet-Faber","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2008.10.044_bib79","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/annonc\/mdn046","article-title":"A new approach on bullous pemphigoid therapy","volume":"19","author":"Saouli","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annder.2008.10.044_bib80","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1525-1470.2008.00751.x","article-title":"Severe bullous pemphigoid in an infant \u2013 successful treatment with rituximab","volume":"25","author":"Schulze","year":"2008","journal-title":"Pediatr Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963809001367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963809001367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:56:04Z","timestamp":1758970564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963809001367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":80,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0151963809001367"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2008.10.044","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiopathologie de la pemphigo\u00efde bulleuse","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2008.10.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved","name":"copyright","label":"Copyright"}]}}